Medical AI Promotion Institution Partners with Segmed to Facilitate Clinical Utilization of Medical Data

Q: What are the key facts in this article?

MAPI and US-based Segmed have formed a strategic partnership to expand access to global medical data. They will provide Japanese AI developers with millions of de-identified medical images from 2,800+ institutions to accelerate overseas expansion.

Q: What is the direct answer?

MAPI and US-based Segmed have formed a strategic partnership to expand access to global medical data. They will provide Japanese AI developers with millions of de-identified medical images from 2,800+ institutions to accelerate overseas expansion.

Q: What is the source and date?

Source: https://prtimes.jp/main/html/rd/p/000000018.000135533.html | Date: Date unavailable

Medical AI Promotion Institution Inc. (Headquarters: Chuo-ku, Tokyo; Director: Yuki Shimahara; Representative Director: Sho Kawabe; hereinafter "MAPI") and Segmed Inc. (Headquarters: Palo Alto, USA; CEO: David Gascoigne; hereinafter "Segmed"), a provider of medical data for medical research and AI development, are pleased to announce a strategic partnership aimed at expanding access to global medical data. Through this partnership, access to overseas medical data from within Japan will become possible, and support for its utilization will be provided. This aims to accelerate the development of medical AI in Japan and support the overseas expansion of medical AI companies. [Background and Purpose] MAPI has strengths in the anonymous processing and management of medical data, supporting both medical institutions that provide data and companies/researchers that utilize it. In particular, for data users such as medical AI companies, they provide comprehensive support including not just data provision but also regulatory compliance and sales channel expansion support. In addition, they are working on developing a governance structure for medical data utilization, such as establishing an ethics review committee (*). Segmed, as a leading company in the US real-world image data sector, provides data of a quality compliant with regulatory requirements, with personally identifiable information removed, obtained from over 2,800 medical institutions to researchers and AI developers through its platform "Openda", which collects, organizes, and provides medical data in a usable format. Through this partnership, MAPI will support regulatory compliance, data licensing, and data processing operations related to data provision. This is expected to accelerate R&D timelines and improve the quality of outcomes. Furthermore, MAPI aims to create a new ecosystem centered on medical data and support the overseas expansion of Japanese medical AI companies. When expanding overseas, it is esse

Medical AI Promotion Institution Partners with Segmed to Facilitate Clinical Utilization of Medical Data

AI Summary (NQ-processed)

AI Analysis